» Articles » PMID: 32296069

Lymphopenia Predicts Disease Severity of COVID-19: a Descriptive and Predictive Study

Overview
Date 2020 Apr 17
PMID 32296069
Citations 949
Authors
Affiliations
Soon will be listed here.
Citing Articles

Identifying and Validating Prognostic Hyper-Inflammatory and Hypo-Inflammatory COVID-19 Clinical Phenotypes Using Machine Learning Methods.

Ji X, Guo Y, Tang L, Gao C J Inflamm Res. 2025; 18:3009-3024.

PMID: 40034687 PMC: 11874972. DOI: 10.2147/JIR.S504028.


Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease.

Naiditch H, Betts M, Larman H, Levi M, Rosenberg A Front Immunol. 2025; 15:1376654.

PMID: 40012912 PMC: 11861071. DOI: 10.3389/fimmu.2024.1376654.


Lymphocyte Inhibition Mechanisms and Immune Checkpoints in COVID-19: Insights into Prognostic Markers and Disease Severity.

Schniederova M, Bobcakova A, Grendar M, Markocsy A, Ceres A, Cibulka M Medicina (Kaunas). 2025; 61(2).

PMID: 40005306 PMC: 11857393. DOI: 10.3390/medicina61020189.


Comparison of Platelet Indices, Lymphocyte, and Systemic Inflammation Indices on Days 1 and 8 in Surviving and Non-Surviving COVID-19 Patients at Hasan Sadikin General Hospital, Bandung, Indonesia.

Harti G, Maulida S, Susandi E, Fadjari T, Sumardi U, Alisjahbana B J Blood Med. 2025; 16:61-74.

PMID: 39926111 PMC: 11806915. DOI: 10.2147/JBM.S499023.


The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19.

Hernandez-Blanco C, Al-Akioui-Sanz K, Herrera L, Aguirre-Portoles C, Lozano-Ojalvo D, Perez-Rodriguez L iScience. 2025; 28(2):111698.

PMID: 39877904 PMC: 11772958. DOI: 10.1016/j.isci.2024.111698.